Short Interest in Optimi Health Corp. (NASDAQ:OPTH) Declines By 44.5%

Optimi Health Corp. (NASDAQ:OPTH) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 9,806 shares, a decline of 44.5% from the August 15th total of 17,682 shares. Based on an average daily trading volume, of 20,884 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.2% of the shares of the company are sold short.

Optimi Health Price Performance

NASDAQ:OPTH remained flat at $4.76 during trading hours on Tuesday. 77,323 shares of the company traded hands, compared to its average volume of 98,363. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.06 and a quick ratio of 0.03. Optimi Health has a 1 year low of $4.00 and a 1 year high of $6.40. The company’s fifty day moving average is $4.77. The company has a market cap of $27.26 million and a P/E ratio of -6.26.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Optimi Health to a “hold” rating in a research note on Saturday, July 25th. Weiss Ratings upgraded shares of Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. Finally, Zacks Research upgraded Optimi Health to a “hold” rating in a research note on Thursday, May 28th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce”.

Optimi Health Company Profile

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.